Trials / Withdrawn
WithdrawnNCT04068402
Vivio AS (Aortic Stenosis) Algorithm Optimization Study
Optimization of the Vivio System Algorithm as an Aid in the Identification of Heart Sounds Associated With Severe Aortic Stenosis
- Status
- Withdrawn
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 0 (actual)
- Sponsor
- Avicena LLC · Industry
- Sex
- All
- Age
- 21 Years
- Healthy volunteers
- Accepted
Summary
Optimize a candidate software algorithm using data collected with the Vivio system for use as an aid in the identification of heart sounds associated with severe aortic stenosis
Detailed description
Prospective, non-randomized, single-center study of adult subjects referred for echocardiography. Total of 200 enrolled subjects at 1 site Enrolled subjects will undergo: Vivio system data capture, standard of care transthoracic echocardiogram (TTE). Vivio analysis will not be available to non-Avicena personnel
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Vivio System | The Vivio System is an electronic auscultatory device and optical sensor, plus software application intended to provide support to the physician in the evaluation of heart sounds in patients. The product will analyze the acoustic signals of the heart and signals from a captured arterial (carotid) waveform. The analysis procedure will identify and analyze specific heart sounds and arterial waveform features captured by the Vivio device, to devise a scoring system for severe aortic stenosis. |
Timeline
- Start date
- 2019-06-27
- Primary completion
- 2019-08-31
- Completion
- 2019-10-30
- First posted
- 2019-08-28
- Last updated
- 2022-07-20
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT04068402. Inclusion in this directory is not an endorsement.